These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 5425511)
21. Effect of cytostatics on the replication of vaccinia, pseudo-rabies and Sindbis viruses and on the interferon production by tissue culture cells. Rosztóczy I; Mécs I Acta Microbiol Acad Sci Hung; 1968; 15(1):41-7. PubMed ID: 5657098 [No Abstract] [Full Text] [Related]
22. [The first answer to viral infections: type I interferon]. Pichlmair A; Pollak M; Bergthaler A Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051 [TBL] [Abstract][Full Text] [Related]
23. Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Preble OT; Friedman RM Lab Invest; 1983 Jul; 49(1):4-18. PubMed ID: 6191121 [TBL] [Abstract][Full Text] [Related]
24. [Interferons produced by the cells of newborn mice in the presence of sera from newborn and adult animals]. Malinovskaia VV; Litovchenko VG; Balandin IG Biull Eksp Biol Med; 1981 Oct; 91(10):460-2. PubMed ID: 6172164 [TBL] [Abstract][Full Text] [Related]
27. The interferon response circuit in antiviral host defense. Haller O; Weber F Verh K Acad Geneeskd Belg; 2009; 71(1-2):73-86. PubMed ID: 19739399 [TBL] [Abstract][Full Text] [Related]
28. [Effect of remantadine and ribavirin on the production and antiviral action of human interferon types I and II]. Nosik DN; Aspetov RD; Novokhatskiĭ AS Antibiotiki; 1982 Jan; 27(1):49-54. PubMed ID: 6174074 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA. McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379 [TBL] [Abstract][Full Text] [Related]
30. [Antiviral properties of polynucleotides not associated with interferon induction]. Shved AD Mikrobiol Zh (1978); 1982; 44(3):75-85. PubMed ID: 6181384 [No Abstract] [Full Text] [Related]
31. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells. Romanutti C; Castilla V; Coto CE; Wachsman MB Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263 [TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy in human virus infections. IV. Other antiviral agents and interferon]. Campillo Sáinz C Gac Med Mex; 1967 Apr; 97(4):416-9. PubMed ID: 5607709 [No Abstract] [Full Text] [Related]
33. Depression of viral interferon induction in cell monolayers by asbestos fibers. Hahon N; Eckert HL Environ Res; 1976 Feb; 11(1):52-65. PubMed ID: 1253772 [No Abstract] [Full Text] [Related]
34. A practitioner's guide to interferon. Warren SL Ann Allergy; 1980 Jul; 45(1):37-42. PubMed ID: 6157337 [TBL] [Abstract][Full Text] [Related]
35. Antiviral agents in practice. Can Med Assoc J; 1968 Jun; 98(22):1066-8. PubMed ID: 5661063 [No Abstract] [Full Text] [Related]
36. Inhibition of interferon action by toyocamycin. Periés J; Canivet M; Godard C; Sallé M; Tavitian A J Gen Virol; 1974 Jun; 23(3):347-50. PubMed ID: 4836911 [No Abstract] [Full Text] [Related]
37. CURRENT STATUS OF ANTIVIRAL SUBSTANCES. KATZ SL; CARVER DH Postgrad Med; 1963 Sep; 34():222-7. PubMed ID: 14045780 [No Abstract] [Full Text] [Related]
38. The effect of 6-mercaptopurine on the synthesis and action of interferon. St Geme JW; Horrigan DS; Toyama PS Proc Soc Exp Biol Med; 1969 Mar; 130(3):852-5. PubMed ID: 5773678 [No Abstract] [Full Text] [Related]
39. [Recent topics on interferon-inducing agents]. Ujihara M; Kawade Y Tanpakushitsu Kakusan Koso; 1968 Jun; 13(7):695-7. PubMed ID: 4882144 [No Abstract] [Full Text] [Related]
40. [Study of species-specific cellular antigens in several RNA viruses by means of inducing immunologic tolerance to them in mice]. Chepulis GK; Zhdanov VM Vestn Akad Med Nauk SSSR; 1969; 24(12):42-4. PubMed ID: 5387352 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]